March 10, 2014
(Stock Blog Hub, 4/27/13)
Pacira Pharmaceuticals, Inc.(PCRX) recently announced positive data from a phase IV study, EXCLAIM, evaluating the use of Exparel for postsurgical analgesia in patients...(read more)
Optibase Ltd. (NASDAQ: OBAS) today announced financial results for the third quarter ended September 30, 2010. Revenues from fixed income real estate totaled $400,000 for the quarter ended September 30, 2010, compared with $408,000...(read more)
(Money Morning, 11/7/07)
Optibase Narrows Loss; Manulife Profits Jump 10% Profits; Biggest Takeover Ever Down Under; ING Sidesteps Subprime Pains - Maybe Optibase Ltd. (OBAS), an advanced digital-video solutions based in Israel, announced that third-quarter revenue soared 21% to $5.2 million - up from [...]
Optibase (OBAS) Company Overview
There is no analysis for OBAS yet. But you can go to Wikinvest to help create one!